When was Kyowa Kirin founded?

Kyowa Kirin was founded in 1949.

Where is Kyowa Kirin located?

Kyowa Kirin is headquartered in Chiyoda City, Japan.

How many employees does Kyowa Kirin have?

As of May 31, 2026, the latest employee count at Kyowa Kirin is 697.

Is Kyowa Kirin a funded company?

Kyowa Kirin is a funded company, having raised a total of $***** in its 1st and only funding round.

What is the annual revenue of Kyowa Kirin?

Annual revenue of Kyowa Kirin is less than £1M as on Aug 31, 2023

Where does Kyowa Kirin rank among its competitors?

Kyowa Kirin ranks 675th amongst 3272 active competitors, of which 1116 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Immuneel, which secured $10.5M in Jun, 2026.

Who are the top competitors of Kyowa Kirin?

Kyowa Kirin's top competitors include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Among them, Immuneel secured the most recent funding round in June, 2026.

Kyowa Kirin - 2026 Company Profile, Funding, Competitors & Financials

Kyowa Kirin is a funded company based in Chiyoda City (Japan), founded in 1949. It operates as a Developer of biologics for multiple diseases and disorders. The company has 3272 active competitors, including 1116 funded and 774 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences.

Company Details

Developer of biologics for multiple diseases and disorders. The company develops next-generation drugs, nucleic-acid drugs, and regenerative medicine. The product portfolio includes Abstral, brodalumab, PecFent, coniel, and more.

Key Metrics

Founded Year

1949

Location

Chiyoda City, Japan

Stage

Funding Raised

Investors

Plexus Ventures

Ranked

675^th among 3272 active competitors

Annual Revenue

£0 - £1M as on Aug 31, 2023

Employee Count

697 as on May 31, 2026

Investment & Acquisitions

Orchard Therapeutics & 3 more

Similar Companies

Jazz Pharmaceuticals & 2976 more

View Kyowa Kirin's full profile

Kyowa Kirin is associated with 11 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Global Kira s.r.o. CIN: 19259387 , Czech Republic, Active	Apr 25, 2023	-	-
Kioa Investment s.r.o. CIN: 27622665 , Czech Republic, Active	Nov 09, 2006	-	-
KYOWA KIRIN INTERNATIONAL PLC CIN: SC198780 , United Kingdom, Active	Aug 09, 1999	-	99 (As on Dec 31, 2021)
VALUE pharma s.r.o. CIN: 24672980 , Czech Republic, Active	Apr 30, 2010	-	-
Kyowa Kirin, Inc. CIN: 0018y00000ArzdEAAR , United States, Active	Jan 04, 2024	-	-	-
Kyowa Kirin Pharma s.r.o. CIN: 06583521 , Czech Republic, Active	Nov 09, 2017	-	-
Ltd KIRA s.r.o. CIN: 28965353 , Czech Republic, Active	Sep 23, 2009	-	-
KIRIN DIGITAL LTD CIN: 12053882 , United Kingdom, Active	Jun 16, 2019	£0 - £1M (As on Aug 31, 2023)	1 (As on Aug 31, 2025)
Parvel Farmaceutica s.r.o. CIN: 17662559 , Czech Republic, Active	Oct 23, 2022	-	-
KYOWA KIRIN AB CIN: 999034837 , Norway, Active	Apr 14, 2004	-	-
Kyowa Kirin GmbH CIN: R1101_HRB65310 , Germany, Deadpooled	Mar 21, 2011	-	-

Kyowa Kirin is a funded company. Kyowa Kirin has 1 institutional investor.

View details of Kyowa Kirin's funding rounds and investors

Kyowa Kirin's employee count trend

Kyowa Kirin has 697 employees as of May 26. Here is Kyowa Kirin's employee count trend over the years:

Uncover Kyowa Kirin's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Kyowa Kirin include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Here is the list of Top 10 competitors of Kyowa Kirin, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	82/100
2nd	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating various human diseases	$821M	Baillie Gifford, Google Ventures & 17 others	74/100
3rd	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	BVF Partners, Boxer Capital & 15 others	73/100
4th	Senti Bio 2016, San Francisco (United States), Public	Developer of cell and gene therapies for patients living with incurable diseases	$158M	Celadon Partners, New Enterprise Associates ... & 30 others	72/100
5th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
6th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Fidelity Investments, Domain Associates & 19 others	72/100
7th	Karyopharm 2008, Newton (United States), Public	Biopharmaceutical company focused on developing and commercializing innovative cancer therapies	$98.4M	Foresite Capital, Avidity Partners & 16 others	72/100
8th	Moderna 2010, Cambridge (United States), Public	Developer of mRNA-based therapeutics for a wide range of diseases	$2.78B	Merck, AstraZeneca & 32 others	71/100
9th	Immuneel 2018, Bengaluru (India), Series B	Developer of T-cell therapies for the treatment of cancer	$49.8M	True North, F-Prime Capital & 23 others	71/100
10th	C4 Therapeutics 2016, Cambridge (United States), Public	Developer of small molecule drugs for treating cancer	$223M	Cobro Ventures, Perceptive Advisors & 27 others	71/100
675th	Kyowa Kirin 1949, Chiyoda City (Japan), Funding Raised	Developer of biologics for multiple diseases and disorders	-	Plexus Ventures	48/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Kyowa Kirin's competitors? Click here to see the top ones

Kyowa Kirin has made 3 investments in companies including Ring Therapeutics and Cellarity. Kyowa Kirin has also acquired 1 companies including Orchard Therapeutics.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Oct 05, 2023	Acquisition	Orchard Therapeutics	2015	London (United Kingdom)
Mar 09, 2023	Investments	Ring Therapeutics	2018	Cambridge (United States)
Oct 04, 2022	Investments	Cellarity	2015	Cambridge (United States)